IMRN Stock Analysis: Buy, Sell, or Hold?
IMRN - Immuron Limited American Depositary Shares
$1.37
0.04 (3.41%)
▲
5d:
+11.89%
30d:
+69.4%
90d:
+82.91%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Feb 26, 2026
0d
Get Alerted When IMRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called IMRN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: IMRN is 31.2% above its trading range ($1.04). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: IMRN is 31.2% above its trading range ($1.04). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: IMRN is currently trading at $1.36, which is considered extended relative to its 30-day fair value range of $0.80 to $1.04.
Technical Outlook: Technically, IMRN is in a uptrend. Immediate support is located at $0.95, while resistance sits at $1.60. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: IMRN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+192.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMRN is in a uptrend. Immediate support is located at $0.95, while resistance sits at $1.60. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: IMRN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+192.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.80 -
$1.04
Company Quality Score
61/100
(BUY)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+31.2% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: Strong upward momentum (+3.4%)
- BULLISH: Trading 192.8% below Wall St target ($4.00)
- WARNING: Recommendation downgraded due to 31.2% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.80 -
$1.04
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.60
Current Trend
Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-90.40
Wall Street Target
$4.00
(+192.8%)
Revenue Growth (YoY)
4.8%
Profit Margin
-62.1%
Share & Embed Analysis
Last updated: June 03, 2026 7:35 PM ET
Data refreshes hourly during market hours. Next update: 8:35 PM
Data refreshes hourly during market hours. Next update: 8:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 54 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 55 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 56 HOLD |
